Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation

Table 2

An overview of liver biochemistry (transaminase leak as surrogate marker for the reperfusion injury) as well as the early and late transplant outcome in recipients receiving livers from high risk donors (DRI ≥ 2, n = 83).

	Low bilirubin (<2.04 mg/L) ()	High bilirubin (>2.04 mg/L) ()	p value
AST day 1 (±SD)	2358 ± 3882	1194 ± 1411	0.02
AST day 2 (±SD)	1894 ± 3411	852 ± 1176	0.05
AST day 7 (±SD)	70 ± 58	70 ± 41	0.99
ALT day 1 (±SD)	1205 ± 1117	894 ± 823	0.09
ALT day 2 (±SD)	1370 ± 1411	911 ± 882	0.15
ALT day 7 (±SD)	258 ± 235	211 ± 117	0.33
EGD (n, %)	11 (44%)	24 (41%)	1
Re-Tx within 1 month (n, %)	5 (20%)	1 (1.8%)	0.01
Re-tx within 1 year (n, %)	7 (28%)	4 (7.5%)	0.01
Death within 1 month (n, %)	0	1 (1.8%)	1
Death within 1 year (n, %)	1 (4%)	4 (6.8%)	1